Q: Hello Peter,
I like your response from the previous question on Canntrust but I would appreciate it if you can provide comments as to why this company which has been touted by analysts and BNN guests as one of the better players in the cannibis space, yet it has performed poorly when compared to most of the mid and large cap players. When you look at the chart from inception to now, Canntrust has not done well. Their fundamentals and strategy appear to be sound but why such a gap (comparing to weed, acb, cron, hexo, ogi, etc).
Also, on another note, KSHB, Kush holdings is bascially a picks and shovels play in the US for cannibis packaging etc and only trades over the counter (not on your list). It plans to list on nasdaq or nyse. If this happens, what would happen to my shares if they were bought over the counter. Would i be able to sell same shares on nyse or nasdaq. Apppreciate it.
I like your response from the previous question on Canntrust but I would appreciate it if you can provide comments as to why this company which has been touted by analysts and BNN guests as one of the better players in the cannibis space, yet it has performed poorly when compared to most of the mid and large cap players. When you look at the chart from inception to now, Canntrust has not done well. Their fundamentals and strategy appear to be sound but why such a gap (comparing to weed, acb, cron, hexo, ogi, etc).
Also, on another note, KSHB, Kush holdings is bascially a picks and shovels play in the US for cannibis packaging etc and only trades over the counter (not on your list). It plans to list on nasdaq or nyse. If this happens, what would happen to my shares if they were bought over the counter. Would i be able to sell same shares on nyse or nasdaq. Apppreciate it.